Suppr超能文献

菲律宾分化型甲状腺癌患者复发的风险因素。

Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer.

机构信息

Section of Endocrinology Diabetes and Metabolism, Department of Medicine, Philippine General Hospital, University of the Philippines, Manila, Philippines.

出版信息

Endocrinol Metab (Seoul). 2015 Dec;30(4):543-50. doi: 10.3803/EnM.2015.30.4.543. Epub 2015 Oct 20.

Abstract

BACKGROUND

The incidence of well-differentiated thyroid cancer (WDTC) has increased in recent years. Despite its excellent prognosis, increasing morbidity from recurrent diseases continues to affect long-term outcomes. Among at-risk populations, Filipinos have the highest incidence of thyroid cancer worldwide, characterized by a highly aggressive and recurrent form of disease. Here, we sought to identify risk factors associated with disease recurrence among Filipinos with WDTC.

METHODS

This retrospective cohort study examined 723 patients diagnosed with WDTC seen at Philippine General Hospital. Affected individuals were classified based on the presence or absence of disease recurrence. Multivariate logistic regression analyses were used to determine significant predictors of recurrence.

RESULTS

Multiple risk factors, including age >45 years (odds ratio [OR], 1.44), multifocality of cancer (OR, 1.43), nodal involvement (OR, 4.0), and distant metastases at presentation (OR, 2.78), were significantly associated with a recurrence of papillary thyroid cancer (PTC). In contrast, follicular variant histology (OR, 0.60) and postsurgical radioactive iodine therapy (OR, 0.31) were protective for PTC recurrence. Distant metastases at presentation (OR, 19.4) and postsurgical radioactive iodine therapy (OR, 0.41) were associated with follicular thyroid cancer (FTC) recurrence.

CONCLUSION

Lymph node metastases at presentation was the strongest predictor of recurrence in PTC, whereas distant metastases at presentation was the strongest for FTC recurrence. Among Filipinos, stratification of WDTC patients based on recurrence risk factors identified in this study will be helpful in guiding the intensity of treatment strategies and long-term thyroid cancer surveillance.

摘要

背景

近年来,分化型甲状腺癌(WDTC)的发病率有所增加。尽管其预后良好,但复发性疾病的发病率增加仍持续影响长期预后。在高危人群中,菲律宾人是全世界甲状腺癌发病率最高的人群,其疾病表现为高度侵袭性和复发性。在此,我们旨在确定与菲律宾 WDTC 患者疾病复发相关的风险因素。

方法

本回顾性队列研究共纳入在菲律宾总医院就诊的 723 例 WDTC 患者。根据疾病是否复发对患者进行分类。采用多变量逻辑回归分析确定复发的显著预测因素。

结果

多种风险因素与 WDTC 患者的 PTC 复发显著相关,包括年龄>45 岁(比值比[OR],1.44)、癌症多灶性(OR,1.43)、淋巴结受累(OR,4.0)和初诊时远处转移(OR,2.78)。相反,滤泡状变异组织学(OR,0.60)和术后放射性碘治疗(OR,0.31)对 PTC 复发具有保护作用。初诊时远处转移(OR,19.4)和术后放射性碘治疗(OR,0.41)与滤泡状甲状腺癌(FTC)复发相关。

结论

初诊时淋巴结转移是 PTC 复发的最强预测因素,而初诊时远处转移是 FTC 复发的最强预测因素。在菲律宾人中,基于本研究确定的复发风险因素对 WDTC 患者进行分层,有助于指导治疗策略的强度和长期甲状腺癌监测。

相似文献

1
Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer.
Endocrinol Metab (Seoul). 2015 Dec;30(4):543-50. doi: 10.3803/EnM.2015.30.4.543. Epub 2015 Oct 20.
2
Well-Differentiated Thyroid Cancer: The Philippine General Hospital Experience.
Endocrinol Metab (Seoul). 2016 Mar;31(1):72-9. doi: 10.3803/EnM.2016.31.1.72.
4
Does every classical type of well-differentiated thyroid cancer have excellent prognosis? A case series and literature review.
Cancer Manag Res. 2019 Apr 1;11:2441-2448. doi: 10.2147/CMAR.S198514. eCollection 2019.
5
Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Cancer. 1996 Jan 1;77(1):172-80. doi: 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1.
6
7
Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.
Thyroid. 2016 Feb;26(2):227-34. doi: 10.1089/thy.2015.0401. Epub 2016 Jan 7.
8
Management and outcome of recurrent well-differentiated thyroid carcinoma.
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
9
Thyroid cancer in childhood: a retrospective review of childhood course.
Thyroid. 2010 Apr;20(4):375-80. doi: 10.1089/thy.2009.0386.
10
Single liver metastasis of a follicular variant of papillary thyroid carcinoma: a rare pattern of organ spread.
Endocrinol Diabetes Metab Case Rep. 2020 Aug 20;2020. doi: 10.1530/EDM-20-0074.

引用本文的文献

1
The Initial Risk Stratification System for Differentiated Thyroid Cancer: Key Updates in the 2024 Korean Thyroid Association Guideline.
Endocrinol Metab (Seoul). 2025 Jun;40(3):357-384. doi: 10.3803/EnM.2025.2465. Epub 2025 Jun 24.
5
Incidence, Recurrence and Mortality Among Filipinos With Differentiated Thyroid Cancer: A Systematic Review.
J ASEAN Fed Endocr Soc. 2023;38(1):100-107. doi: 10.15605/jafes.038.01.14. Epub 2023 Mar 2.
6
Characterization of mortality and high-risk characteristics of thyroid cancer in Filipinos using the California Cancer Registry.
Front Public Health. 2023 Jan 19;10:1104607. doi: 10.3389/fpubh.2022.1104607. eCollection 2022.
8
Differential Expression of Non-Coding RNA Signatures in Thyroid Cancer between Two Ethnic Groups.
Curr Oncol. 2021 Sep 19;28(5):3610-3628. doi: 10.3390/curroncol28050309.

本文引用的文献

1
Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer.
Ann Surg Oncol. 2014 Jun;21(6):1884-90. doi: 10.1245/s10434-014-3507-y. Epub 2014 Feb 11.
2
Recurrent well-differentiated thyroid carcinoma.
Oral Oncol. 2013 Jul;49(7):689-94. doi: 10.1016/j.oraloncology.2013.03.434. Epub 2013 Apr 25.
4
Occult lymph node metastases increase locoregional recurrence in differentiated thyroid carcinoma.
Ann Otol Rhinol Laryngol. 2012 May;121(5):283-90. doi: 10.1177/000348941212100501.
7
9
Papillary carcinoma tall cell variant (TCV): a review.
Endocr Pathol. 2010 Mar;21(1):12-5. doi: 10.1007/s12022-010-9106-y.
10
Thyroid cancer outcomes in Filipino patients.
Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):138-42. doi: 10.1001/archoto.2009.206.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验